Literature DB >> 3040392

Perinatal viral infections.

C G Prober, A M Arvin.   

Abstract

In comparison to older children and adults, neonates are immunologically incompetent. They are susceptible to infections caused by a variety of microorganisms, including bacteria, fungi and viruses. These infectious agents may be acquired by neonates either prenatally, during the intrapartum period or postnatally. The purpose of this review is to emphasize the potential impact of viral infections contracted by neonates at the time of delivery or within the neonatal period. The viruses reviewed include the herpes group of viruses (cytomegalovirus, herpes simplex viruses and varicella-zoster virus), type B hepatitis virus, human immunodeficiency virus, respiratory viruses, enteroviruses, rotavirus and human papilloma virus. For each virus the potential sources and incidence of the infection, the common manifestations of the illness, and possible means of prevention and therapy are discussed. Although infections caused by bacteria tend to be more clinically dramatic and more immediately life-threatening, it is emphasized that infections caused by viruses are common and associated with substantial long-term morbidity. Perinatal viral infections need to be recognized as early in life as possible so that their natural history can be more completely defined and any possible intervention made.

Entities:  

Mesh:

Year:  1987        PMID: 3040392      PMCID: PMC7087940          DOI: 10.1007/BF02017608

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  142 in total

1.  Life table analysis of children with acquired immunodeficiency syndrome.

Authors:  R Lampert; J Milberg; R O'Donnell; A Kristal; P Thomas
Journal:  Pediatr Infect Dis       Date:  1986 May-Jun

2.  Nursery-acquired cytomegalovirus infection in two premature infants.

Authors:  A S Yeager; H Jacobs; J Clark
Journal:  J Pediatr       Date:  1972-08       Impact factor: 4.406

3.  Letter: Hepatitis-B surface antigen in breast milk.

Authors:  E H Boxall; T H Flewett; D S Dane; C H Cameron; F O MacCallum; T W Lee
Journal:  Lancet       Date:  1974-10-26       Impact factor: 79.321

4.  Deficiency of immune interferon production by leukocytes of normal newborns.

Authors:  Y J Bryson; H S Winter; S E Gard; T J Fischer; E R Stiehm
Journal:  Cell Immunol       Date:  1980-09-15       Impact factor: 4.868

5.  Vertical transmission of the hepatitis B surface antigen.

Authors:  I L Schweitzer
Journal:  Am J Med Sci       Date:  1975 Sep-Oct       Impact factor: 2.378

6.  Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody.

Authors:  C Ching; C Lopez
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

7.  A simultaneous outbreak of respiratory syncytial virus and parainfluenza virus type 3 in a newborn nursery.

Authors:  H C Meissner; S A Murray; M A Kiernan; D R Snydman; K McIntosh
Journal:  J Pediatr       Date:  1984-05       Impact factor: 4.406

Review 8.  Perinatal echovirus infection: insights from a literature review of 61 cases of serious infection and 16 outbreaks in nurseries.

Authors:  J F Modlin
Journal:  Rev Infect Dis       Date:  1986 Nov-Dec

9.  Transfusion-associated cytomegalovirus infection and acquired immune deficiency syndrome in an infant.

Authors:  K Shannon; E Ball; R L Wasserman; F K Murphy; J Luby; G R Buchanan
Journal:  J Pediatr       Date:  1983-12       Impact factor: 4.406

10.  Cytomegalovirus infections in neonates acquired by blood transfusions.

Authors:  S P Adler; T Chandrika; L Lawrence; J Baggett
Journal:  Pediatr Infect Dis       Date:  1983 Mar-Apr
View more
  2 in total

1.  Antibody prevents the establishment of persistent arenavirus infection in synergy with endogenous T cells.

Authors:  J R Baldridge; T S McGraw; A Paoletti; M J Buchmeier
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

Review 2.  Role of the virology laboratory in diagnosis and management of patients with central nervous system disease.

Authors:  T Chonmaitree; C D Baldwin; H L Lucia
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.